Pilot Study Of The Effect Of Rifaximin On B-Cell Dysregulation In Cirrhosis
Clinical trial NCT01951209 · TERMINATED
Trial details
- NCT number
- NCT01951209
- Sponsor
- David E. Kaplan, MD MSc
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-17
- Primary completion
- 2016-11-17
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.